Processa Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$12,469
Gross Profit
6,234
EBITDA
-3,436
-3,950
-2,846
-2,734
EBIT
-3,436
-3,950
-2,846
-2,734
Net Income
-3,436
-3,933
-2,834
-2,728
Net Change In Cash
0
0
0
12,469
Free Cash Flow
-3,484
-2,270
-2,729
-2,247
Cash
6,308
6,936
2,897
1,191
Basic Shares
47
15
9
3,509

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-874
-875
EBITDA
-12,050
-11,456
-19,468
-10,775
EBIT
-12,051
-11,457
-20,257
-11,566
Net Income
-11,850
-11,121
-27,424
-11,427
Net Change In Cash
0
0
0
0
Free Cash Flow
-11,248
-8,066
-9,605
-8,717
Cash
1,191
4,706
6,503
16,497
Basic Shares
3,059
1,311
16,109
765

Earnings Calls

QuarterEPS
2025-09-30
-$0.07
2025-06-30
-$0.25
2025-03-31
-$0.30
2024-12-31
-$0.74